Preemptive therapy for genetic disease

被引：10

作者：

Blau, CA ^{[1
]}

Stamatoyannopoulos, G ^{[1
]}

机构：

[1] UNIV WASHINGTON,DIV MED GENET,SEATTLE,WA 98195

来源：

NATURE MEDICINE | 1996年 / 2卷 / 02期

关键词：

D O I：

10.1038/nm0296-161

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：161 / 162

页数：2

共 7 条

[1]

BUCKLEY RH, 1986, J IMMUNOL, V136, P2398

[2]

COWAN MJ, 1994, AM J PEDIAT HEMATOL, V16, P35

[3]

Flake A. W., 1995, Blood, V86, p125A

[4] ANALYSIS OF BETA-GLOBIN MUTATIONS SHOWS STABLE MIXED CHIMERISM IN PATIENTS WITH THALASSEMIA AFTER BONE-MARROW TRANSPLANTATION [J].

KAPELUSHNIK, J ;

OR, R ;

FILON, D ;

NAGLER, A ;

CIVIDALLI, G ;

AKER, M ;

NAPARSTEK, E ;

SLAVIN, S ;

OPPENHEIM, A .

BLOOD, 1995, 86 (08) :3241-3246

[5] MARROW TRANSPLANTATION IN PATIENTS WITH THALASSEMIA RESPONSIVE TO IRON CHELATION-THERAPY [J].

LUCARELLI, G ;

GALIMBERTI, M ;

POLCHI, P ;

ANGELUCCI, E ;

BARONCIANI, D ;

GIARDINI, C ;

ANDREANI, M ;

AGOSTINELLI, F ;

ALBERTINI, F ;

CLIFT, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (12) :840-844

[6]

NESCI S, 1992, BONE MARROW TRANSPL, V10, P143

[7] INTERLEUKIN-2 RECEPTOR GAMMA CHAIN MUTATION RESULTS IN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN HUMANS [J].

NOGUCHI, M ;

YI, HF ;

ROSENBLATT, HM ;

FILIPOVICH, AH ;

ADELSTEIN, S ;

MODI, WS ;

MCBRIDE, OW ;

LEONARD, WJ .

CELL, 1993, 73 (01) :147-157

← 1 →